根据该协议,Catalent将向TFF提供其扩大规模的专业知识和制造能力,作为其首选的开发和制造合作伙伴,Catalent将能够向其客户提供TFF技术,这有可能增加...查看全文
美港电讯APP2020-09-24 21:21
TFF制药(TFFP.O):在实验中,发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆,公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ (来自美港电讯APP)查看全文
chuminhua2020-08-14 10:55
8月13日,TFF Pharmaceuticals,Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司,专注于根据其专利的薄膜冷冻(TFF)技术平台开发和商业化创新药物产品,宣布已与UNION therapeutics签订了一项全球独家许可协议,将其TFF技术与氯硝柳胺(niclosamide)联合使用。根据协议条款,UNI...查看全文
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-20-021860 Act: 34 Size: 153 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-20-021865 Act: 34 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001213900-20-021315 Act: 34 Size: 358 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 内部交易: 2020-05-26,Director,Fletcher Aaron G.L. ,买入,20000普通股, $5.08
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-013471 Size: 4 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-20-012264 Act: 34 Size: 100 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-20-012260 Act: 34 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-20-010404 Act: 34 Size: 180 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-009441 Size: 4 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 内部交易: 2020-04-06,Director,Fletcher Aaron G.L. ,买入,6252普通股, $4.24